News

First treatment for late-stage dry AMD rejected by UK drug regulator

17 February 2025 | AMD, geographic atrophy, Dry, macular society, Apellis, pharma

Leading sight loss charity the Macular Society has responded to the decision not to approve the first potential treatment for geographic atrophy (GA) or late stage dry aged-related macular degeneration. The decision is a significant setback for those affected by...